University of Iowa doctoral student Katie Colling is making progress in identifying hormones that are effective at combating ...
In this study, researchers aimed to determine whether younger BRCA1/2 carriers who undergo oophorectomy can receive menopausal hormone therapy without increasing their risk of breast cancer.
SurvivorNet on MSN
The evERA Trial: A Promising Treatment Option For Patients With Estrogen Receptor-Positive (ER+), HER2-Negative (HER2-) Breast Cancer
The evERA breast cancer trial marks a turning point for some patients with a specific type of advanced breast cancer known as ...
Investigators sought to evaluate changes in the estimated CV risk of men with prostate cancer after 6 months of hormone therapy using clinical tools established for the general population.
Learn what to expect with chemotherapy and hormone therapy, as well as managing fears of recurrence and embracing life after cancer. Today on the pod, we're continuing the conversation around breast ...
Triple-positive breast cancer involves tumors positive for estrogen, progesterone, and HER2 receptors, affecting treatment decisions and strategies. Diagnosis includes imaging and biopsy to confirm ...
Cancer of the prostate has become the leading cause of cancer diagnoses among males in the United Kingdom. Its treatment, ...
Following a mastectomy and hormone treatment, the personal trainer committed to 12 physical challenges in 12 months to raise ...
The benefits of hormone therapy for menopause symptoms often outweigh the risks for many people. However, it may not be a good treatment option for others, including those with a history of blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results